Updated on 2026/06/04

Information

 

写真a

 
KOZAKURA EISHO
 
Organization
Faculty of Pharmaceutical Sciences Department of Chemo-Pharmaceutical Sciences Assistant Professor
School of Pharmaceutical Sciences Department of General Pharmaceutical Sciences(Concurrent)
Title
Assistant Professor

Research Areas

  • Life Science / Pharmaceutical analytical chemistry and physicochemistry

Degree

  • Doctor of Philosophy (Clinical Pharmacy) ( 2026.3 Kyushu University )

Research History

  • Kyushu University Department of Molecular Pathobiology, Faculty of Pharmaceutical Sciences Assistant Professor 

    2026.4 - Present

Education

  • Kyushu University   Graduate School of Pharmaceutical Sciences   Clinical Pharmacy, Doctoral course

    2022.4 - 2026.3

      More details

    Country:Japan

    researchmap

Research Interests・Research Keywords

  • Research theme: Oxidized lipids

    Keyword: Oxidized lipids

    Research period: 2026

  • Research theme: Oxidized phospholipids

    Keyword: Oxidized phospholipids

    Research period: 2026

  • Research theme: Oxidative stress

    Keyword: Oxidative stress

    Research period: 2026

  • Research theme: Mass spectrometry

    Keyword: Mass spectrometry

    Research period: 2026

  • Research theme: Redox

    Keyword: Redox

    Research period: 2026

  • Research theme: Ferroptosis

    Keyword: Ferroptosis

    Research period: 2026

  • Research theme: G protein-coupled receptors (GPCRs)

    Keyword: G protein-coupled receptors (GPCRs)

    Research period: 2026

Papers

  • Palmitic acid induces UCP1-independent mitochondrial depolarization specifically in brown adipose tissue. Reviewed International journal

    Yuto Ishikawa, Isshin Shiiba, Eisho Kozakura, Haruto Yabu, Shun Hirose, Hijiri Oshio, Ken-Ichi Yamada, Yuko Okamatsu-Ogura, Ryoko Inatome, Shigeru Yanagi

    The Journal of biological chemistry   302 ( 3 )   111177 - 111177   2026.3   ISSN:0021-9258 eISSN:1083-351X

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Journal of Biological Chemistry  

    Brown adipose tissue (BAT) is a major site of nonshivering thermogenesis, where mitochondria generate heat instead of ATP. The thermogenesis occurs through the activity of uncoupling protein 1 (UCP1), which specifically resides in the mitochondrial inner membrane and dissipates the mitochondrial proton gradient upon activation by long-chain free fatty acids. Although UCP1-independent proton leak has been reported, the mechanism underlying UCP1-independent mitochondrial membrane depolarization remains largely unknown. Here, using primary brown adipocytes, we found that cold-mimicking stimulation induces mitochondrial membrane depolarization even under UCP1 KO and knockdown conditions. Furthermore, during cold-mimicking stimulation, palmitic acid shows the most prominent increase in a lipolysis-dependent manner. Notably, palmitic acid directly decreases mitochondrial membrane potential specifically in mitochondria isolated from BAT but not in those isolated from liver or brain. These findings suggest that palmitic acid contributes to mitochondrial depolarization in BAT, thereby contributing to UCP1-independent depolarization.

    DOI: 10.1016/j.jbc.2026.111177

    Web of Science

    Scopus

    PubMed

    researchmap

  • Excessive HIF-1α driven by phospholipid metabolism causes septic cardiomyopathy through cytopathic hypoxia. Reviewed International journal

    Masatsugu Watanabe, Masataka Ikeda, Ko Abe, Shun Furusawa, Kosei Ishimaru, Takuya Kanamura, Satoshi Fujita, Hiroko Deguchi Miyamoto, Eisho Kozakura, Yoko Shojima Isayama, Yuki Ikeda, Takashi Kai, Toru Hashimoto, Shouji Matsushima, Tomomi Ide, Ken-Ichi Yamada, Hiroyuki Tsutsui, Ken Yamaura, Kohtaro Abe

    Nature cardiovascular research   4 ( 9 )   1077 - 1093   2025.9   ISSN:2731-0590 eISSN:2731-0590

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Nature Cardiovascular Research  

    Septic cardiomyopathy, one manifestation of multiple organ dysfunction syndrome, is a challenging complication in sepsis, and cytopathic hypoxia has been proposed to have a key role in the pathophysiology of multiple organ dysfunction syndrome. However, the underlying mechanisms remain unknown. Here, we show that upregulation of hypoxia-inducible factor-1α (HIF-1α) in cardiomyocytes following lipopolysaccharide (LPS) treatment suppresses mitochondrial respiration via inducible nitric oxide synthase-dependent nitric oxide, leading to cytopathic hypoxia. Cardiac-specific heterozygous deletion of HIF-1α ameliorates mitochondrial and contractile dysfunction in a mouse model of septic cardiomyopathy. Mechanistically, nuclear factor-κB (NF-κB)-mediated upregulation of cyclooxygenase 2 (COX2) and secretory phospholipases A2 (sPLA2) enhances HIF-1α expression following LPS exposure, whereas their inhibition prevents LPS-induced HIF-1α upregulation, cytopathic hypoxia and contractile dysfunction. In addition, phospholipid metabolites (prostaglandins and lysophospholipids/free fatty acids, respectively) stabilize HIF-1α via protein kinase A activation. These findings highlight a crucial role of excessive HIF-1α, driven by LPS-enhanced phospholipid metabolism, in septic cardiomyopathy through induction of cytopathic hypoxia.

    DOI: 10.1038/s44161-025-00687-1

    Web of Science

    Scopus

    PubMed

    researchmap

  • Identification of novel oxidized phospholipids that activate platelet-activating factor receptor using HPLC fractionation and comprehensive LC-MS/MS analysis. Reviewed International journal

    Eisho Kozakura, Ryoya Ueno, Tomohiro Yamashita, Tomomi Hashidate-Yoshida, Hideo Shindou, Mirinthorn Jutanom, Kazushi Morimoto, Ken-Ichi Yamada

    Biochemical and biophysical research communications   765   151858 - 151858   2025.6   ISSN:0006-291X eISSN:1090-2104

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Biochemical and Biophysical Research Communications  

    Platelet-activating factor receptor (PAFR) is involved in various physiological processes, including the immune system and inflammatory responses. In addition to PAF, several oxidized phospholipids have been shown to act as ligands for PAFR. We have previously developed a comprehensive analysis method for oxidized phospholipids, and in this study, we employed this method to test whether additional oxidized phospholipids can activate PAFR. From an oxidized phosphatidylcholine mixture, we identified that 1-palmitoyl-2-(4'-oxo-butanoyl)-sn-glycero-3-phosphocholine (POBPC) functions as a novel PAFR activator, using preparative HPLC and comprehensive LC-MS/MS analysis of fractionated oxidized phospholipids. Next, multiple assays confirmed that POBPC acts as a bona fide PAFR agonist. The H248W mutation of PAFR attenuated the response to POBPC. Finally, POBPC induced phosphorylation of extracellular signal-regulated kinase in mouse peritoneal macrophages, which endogenously express PAFR. Our findings provide valuable insight into the biological functions of oxidized phospholipids, advancing our understanding of their roles in cellular processes.

    DOI: 10.1016/j.bbrc.2025.151858

    Web of Science

    Scopus

    PubMed

    researchmap

  • Lysosomal lipid peroxidation contributes to ferroptosis induction via lysosomal membrane permeabilization. Reviewed International journal

    Yuma Saimoto, Daiki Kusakabe, Kazushi Morimoto, Yuta Matsuoka, Eisho Kozakura, Nao Kato, Kayoko Tsunematsu, Tomohiro Umeno, Tamiko Kiyotani, Shota Matsumoto, Mieko Tsuji, Tasuku Hirayama, Hideko Nagasawa, Koji Uchida, Satoru Karasawa, Mirinthorn Jutanom, Ken-Ichi Yamada

    Nature communications   16 ( 1 )   3554 - 3554   2025.4   ISSN:2041-1723 eISSN:2041-1723

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Nature Communications  

    Ferroptosis, a form of cell death instigated by iron-dependent lipid peroxidation reactions (LPO), is emerging as a promising therapeutic target for cancer. While the mechanisms governing LPO induction and suppression have gradually been unveiled, questions persist regarding the specific cellular location of LPO and the utilization of iron in driving cell death. A comprehensive understanding of these aspects holds significant potential for advancing therapeutic applications in disease management. Here, we show lysosomal LPO in the initiation of ferroptosis, leveraging the hidden abilities of fluorescent detection probes. Intra-lysosomal LPO triggers iron leakage, fostering cell-wide LPO by augmenting lysosomal membrane permeabilization (LMP). Conversely, cell lines with low susceptibility to ferroptosis do not exhibit LMP. This deficiency is rectified by the concurrent administration of chloroquine, leading to LMP induction and subsequent cell death. These findings underscore enhancing LMP induction efficacy as a strategic approach to surmount resistance to therapies in cancer.

    DOI: 10.1038/s41467-025-58909-w

    Web of Science

    Scopus

    PubMed

    researchmap